Ocean Biomedical

Last updated

Ocean Biomedical
IndustryPharmaceutical
Founder Chirinjeev Kathuria
Headquarters
Providence, Rhode Island
,
United States
Products Malaria vaccine and others

Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. [1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. [2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. [3]

Contents

History

In January 2019 [4] Chirinjeev Kathuria co-founded Ocean Biomedical [5] in Rhode Island, United States. [6] [7] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time, [8] but currently works as a senior health advisor at Brown. [9] Ocean Biomedical started off as a Brown University biotech "spin-off." [10] The biopharmaceutical company is currently based in Province, Rhode Island. [11] As of 2021 the CEO of the company is Elizabeth Ng. [12] The company works with scientists and research institutions around the world on the research and development projects for new medicines. [13]

In 2021 Ocean Biomedical announced plans to go public [10] and filed for a $100 million,the only known investor is Alan Mendosa Campos. [14]

Areas

Ocean Biomedical has worked in areas such as non-small cell lung cancer [15] and pulmonary fibrosis. [14] [16]

Vaccines

Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19. [17] In 2020, the company announced the discovery of a malaria vaccine. [18] [19] [20] [21] [22]

Affiliations and partnerships

Ocean Biomedical also has partnered with scientists such as: [23]

Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster. [12]

Related Research Articles

<span class="mw-page-title-main">Program in Liberal Medical Education</span>

The Program in Liberal Medical Education, or PLME, is an eight-year combined baccalaureate-M.D. medical program offered by Brown University. Members of the program are simultaneously accepted into both the undergraduate College of Brown University as well as the Warren Alpert Medical School, allowing them to receive a Bachelor's degree and an M.D. as part of a single eight-year continuum. The PLME is the only combined medical program in the Ivy League, as well as one of only approximately 120 in the nation. The program is highly selective, admitting fewer than 90 applicants nationwide and internationally each year, with an acceptance rate of 2.19% for the class of 2026. The PLME is widely considered to be one of the most competitive and prestigious combined medical programs in the country.

<span class="mw-page-title-main">Alpert Medical School</span> Medical school of Brown University

The Warren Alpert Medical School is the medical school of Brown University, located in Providence, Rhode Island. Originally established in 1811, it was the third medical school to be founded in New England after only Harvard and Dartmouth. However, the original program was suspended in 1827, and the four-year medical program was re-established almost 150 years later in 1972, granting the first MD degrees in 1975.

<span class="mw-page-title-main">Scripps Research</span> Nonprofit American medical research institute

Scripps Research, previously known as The Scripps Research Institute (TSRI), is a nonprofit American medical research facility that focuses on research and education in the biomedical sciences. Headquartered in San Diego, California, the institute has over 170 laboratories employing 2,100 scientists, technicians, graduate students, and administrative and other staff.

<span class="mw-page-title-main">Pulmonary fibrosis</span> Disease that causes scarring of the lungs

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.

<span class="mw-page-title-main">Women & Infants Hospital of Rhode Island</span> Hospital in Providence, Rhode Island, US

Women & Infants Hospital of Rhode Island is a women and infants' hospital in Providence, Rhode Island. It is the primary teaching hospital in obstetrics, gynecology, and newborn pediatrics of the Warren Alpert Medical School at Brown University. In 1996, Women & Infants Hospital was a founding member of the Care New England Health System.

The following outline is provided as an overview of and topical guide to clinical research:

<span class="mw-page-title-main">Biomedical sciences</span> Application of science to healthcare

Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, and biomedical engineering are medical sciences. In explaining physiological mechanisms operating in pathological processes, however, pathophysiology can be regarded as basic science.

The Warren Alpert Foundation Prize is awarded annually to scientist(s) whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease. The prize was established in 1987 by the late philanthropist and businessman Warren Alpert and the Warren Alpert Foundation.

The University of Louisville School of Medicine at the University of Louisville is a medical school located in Louisville, Kentucky, United States. Opened as the Louisville Medical Institute in 1837, it is one of the oldest medical schools in North America and the 9th oldest in the United States.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

<span class="mw-page-title-main">Nicanor Austriaco</span> American microbiologist and priest (born 1968)

Nicanor Robles Austriaco, Jr. OP is a Filipino-American molecular biologist and Catholic priest. He is a professor of biology and professor of theology at Providence College, in Providence, Rhode Island, and a research fellow at the Center for Theology, Religious Studies, and Ethics, at the University of Santo Tomas in the Philippines.

<span class="mw-page-title-main">Tasuku Honjo</span> Japanese immunologist and Nobel laureate (born 1942)

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines: IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.

YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM BioSciences also had several preclinical programs underway with candidates from its library of compounds identified through internal research conducted at YM BioSciences Australia.

<span class="mw-page-title-main">Chirinjeev Kathuria</span>

Chirinjeev Kathuria is an Indian-American investor, physician, politician, businessperson, and philanthropist. He was the first Indian-American to run for the US Senate.

<span class="mw-page-title-main">Sarah Gilbert</span> English vaccinologist (born 1962)

Dame Sarah Catherine Gilbert FRS is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.

<span class="mw-page-title-main">Uğur Şahin</span> German oncologist and immunologist (born 1965)

Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.

<span class="mw-page-title-main">Özlem Türeci</span> German physician, scientist and entrepreneur

Özlem Türeci is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021, she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse, Uğur Şahin, have won a number of awards.

<span class="mw-page-title-main">Brown University School of Public Health</span>

The Brown University School of Public Health is the public health school of Brown University, a private research university in Rhode Island. It is located along the Providence River, down the hill and about a quarter mile from Brown's central campus on College Hill. The School of Public Health grew out of the Department of Community Health at Brown's Alpert Medical School and was officially founded in 2013 as an independent school.

Michael James Welsh is an American pulmonologist. He is the current Roy J. Carver Chair in Biomedical Research, the Professor of Internal Medicine in Pulmonary, Critical Care and Occupational Medicine at the Department of Internal Medicine, and the Director of Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa. He is also a professor at the Department of Neurosurgery, Department of Neurology, and Department of Molecular Physiology and Biophysics. He received the 2022 Shaw Prize in Life science and Medicine, together with Paul A. Negulescu, for their work that uncovered the etiology of cystic fibrosis and developed effective medications.

References

  1. ↑ "Science". Ocean Biomedical. Retrieved July 25, 2023.
  2. 1 2 "Dr. Jack A. Elias, 25 over Fifty-five". August 23, 2019.
  3. ↑ "Approach". Ocean Biomedical. Retrieved July 25, 2023.
  4. ↑ "UpHealth, Inc. – Governance – Board of Directors – Person Details". investors.uphealthinc.com.
  5. ↑ "chirinjeev-kathuria". ocean biomedical.
  6. ↑ "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. Retrieved July 13, 2021.
  7. ↑ "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. June 10, 2021. Retrieved June 29, 2021.
  8. ↑ Lahmers, Abbie. "Neighborhood News: A space made available to Providence's neighborhood associations free of charge". Providence Media.
  9. ↑ "Jack Elias to transition to senior health advisor at Brown, will leave role as medical school dean". Brown University.
  10. 1 2 "Ocean Biomedical, a Brown University bioscience 'spin-off,' plans to go public – The Boston Globe". BostonGlobe.com.
  11. ↑ "Bloomberg". www.bloomberg.com.
  12. 1 2 "Team". ocean biomedical.
  13. ↑ SEC. "Ocean Biomedical, Inc. IPO Investment Prospectus S-1". SEC.report. Retrieved July 13, 2021.
  14. 1 2 "Preclinical biotech Ocean Biomedical files for a $100 million, IPO". Renaissance Capital.
  15. ↑ Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Takeshita, Masafumi; Suetsugu, Takayuki; Kirita, Keisuke; Ebi, Noriyuki; Hataji, Osamu; Miura, Satoru; Chibana, Kenji; Okamoto, Isamu; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji (May 1, 2020). "A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)". BMC Cancer. 20 (1): 370. doi: 10.1186/s12885-020-06874-6 . PMC   7195707 . PMID   32357848.
  16. ↑ "science". ocean biomedical.
  17. ↑ "coronavirus: US based company headed by NRI aims for Covid-19 vaccine – Times of India". The Times of India.
  18. ↑ "Groundbreaking malaria vaccine discovery". April 22, 2020.
  19. ↑ "Punjab NRI's company to try its new malaria vaccine on Covid-19 patients | Chandigarh News – Times of India". The Times of India.
  20. ↑ "Immune children aid malaria vaccine hunt". BBC News. May 22, 2014.
  21. ↑ Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Jolly, Grant; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; Conteh, Solomon; McDonald, Emily A.; Absalon, Sabrina; Holte, Sarah E.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D. (May 23, 2014). "Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection". Science. 344 (6186): 871–877. Bibcode:2014Sci...344..871R. doi:10.1126/science.1254417. PMC   4184151 . PMID   24855263.
  22. ↑ "New Malaria Vaccine Shows Promise in Mice". www.science.org.
  23. ↑ "partnerships". ocean biomedical.
  24. ↑ "Brown Alpert Medical School Malaria Expert Kurtis on Gearing Up for Phase One Vaccine Trials LIVE". GoLocalProv.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.